Jonathan Zung, Ph.D.
Jonathan Zung, Ph.D. assumed his role as president, WCG Clintrax and advisor to CEO WCG in June 2018. Jonathan is an experienced industry executive with more than 25 years of pharmaceutical development experience in oncology, immunology, cardiovascular disease and other major therapeutic areas. He has held executive leadership positions in the pharmaceutical and pharmaceutical services industries.
Most recently, Jonathan was group president, Clinical Development & Commercialization Services for Covance Drug Development where he led a global organization of over 8,000 employees in 60 countries spanning all phases of development (Phase I- IV), along with global market access services.
Prior to Covance Jonathan was vice president and head of Global Clinical Sciences and Operations at UCB, with responsibility for clinical operations, data management, statistical sciences, contracting, medical writing and operational excellence across the United States, Europe and Asia. Before joining UCB, he was vice president and head of Global Development Operations at Bristol-Myers Squibb, where he led a 1,400-person organization that managed clinical trials from Phase II through registration. He also held several positions of increasing responsibility at Pfizer Global Research and Development.
Jonathan is a member of the board of directors of the Clinical Data Interchange Standards Consortium (CDISC). Previously, he served as chair of the TransCelerate BioPharma operations committee from 2013-2015 and served as a member of The Florida Institute of Technology Board of Trustees from 2010- 2016. He received his doctorate in analytical chemistry from Emory University and has a bachelor’s degree in chemistry from the Florida Institute of Technology.
Phil is WCG Clintrax’s Chief Operating Officer. He joined WCG Clintrax in 2017. Phil is responsible for the payments organization, budgeting and overall operational performance and delivery. Phil works closely with clients to ensure the appropriate solutions and offerings are leveraged to meet their organizational needs.
Phil is a highly accomplished executive with extensive expertise in corporate operations, finance, and business development possessing an extensive career in the research and development of pharmaceuticals and medical devices. Throughout his 20-year career, he has held executive roles leveraging his leadership talents and business acumen to build sound organizational financial structures, develop strategic global partnerships, and form key partnerships. A proven relationship builder and negotiator, he has developed a record of accomplishments in developing strong working relationships with clients, vendors and business partners.
Phil received his Bachelor of Science degree in Business Management from Guilford College. Phil is also a Director and Board Member of the African Heart Initiative, which endeavors to create partnerships to support medical research.
Brooke Millman, J.D. joined WCG Clintrax in 2017 as Vice President, Consulting Solutions, Site Contracting & Payment. Brooke is an industry veteran having started her career in clinical research in 2002. Prior to joining WCG Clintrax, she served as Clinical Legal Director at a large CRO where she was responsible for a team of negotiators who performed client, vendor, and site contracting services.
Prior to this, she held positions of increasing responsibility in the management of NDA submissions and production of scientific and technical papers and presentations.
As market owner and subject matter expert in the field of site contracting and investigator budgeting, Brooke leads the legal and contract negotiations organizations at WCG Clintrax. She is also responsible for supporting the growth of WCG Clintrax. In this role, Brooke strategically guides sponsor clients and CRO partners through the global legal contracting environment in order to achieve their study and operational goals.
Brooke holds a Bachelor of Arts in Communications from Southern Methodist University and a Juris Doctor degree from Mississippi College School of Law.
Eric Babineaux, JD is lead legal counsel and leads a team of attorneys who are involved in developing and implementing contracts in support of clients. Eric joined WCG Clintrax in June 2014 as a Senior Contract Analyst. Eric is a licensed attorney with over 6 years of industry experience negotiating clinical trial agreements globally.
During this time, he has assisted clients in the drafting of global contract templates, the creation of country specific fallback language, and provided internal and external guidance to team members on legal issues arising in the negotiation process.
Eric has a Bachelor’s of Arts in English from Louisiana State University and received his Juris Doctor degree from Wake Forest University.
Sherry Carr is the Director of Global Site Payments at WCG Clintrax since July 2017. Sherry is an experienced industry professional with 10 years of industry experience in the strategy, implementation and system development of global investigator site payments.
As Director of Global Site Payments, Sherry is responsible for providing the strategic direction and operational leadership of the payment organization. This includes providing input on developing and maintaining relationships with clients, identifying process enhancements and providing guidance and support to those processing site payments.
Prior to WCG Clintrax, Sherry served in progressively increasing roles of responsibility at INC Research in the site-payment department. In this capacity, she worked with closely with senior leadership and served as a project manager on process and system improvements.
Sherry received her diploma in Electronic Computer Technology from ECPI Technical University and holds several certificates in business management.
Russell John is the Global Director of Grants Management and Operational Excellence at WCG Clintrax. Russ joined WCG Clintrax in March 2014 and has a diverse background spanning over a decade in the research industry working in the laboratory, at a CRO, and in an SMO.
Through his different roles, he has developed a strong sense of the interrelatedness between the pharmaceutical, clinical site, and service provider components. Russ has been instrumental in leveraging his unique insights, along with this breadth of experience in the industry to the growth of WCG Clintrax to develop the Grants Management and Investigator Payments divisions.
Russ’s passion for operational excellence and agility have allowed him to focus on developing processes that shorten timelines in order to bring treatments to patients in an expeditious manner.
Russ received his Bachelor of Science and Master’s Degree of Secondary Education in Life Sciences from Youngstown State University.
Nicole Palmer is Director of Contracts at WCG Clintrax. She joined WCG Clintrax in July 2016. Nicole is an experienced industry professional with over 10 years of industry experience in oncology, cardiovascular disease and other major therapeutic areas.
As Director of Contracts, Nicole is responsible for providing the strategic direction and oversight of the group along with working closely with clients. . Nicole’s passion for operational excellence is leveraged in optimizing and simplifying processes. During her tenure at WCG Clintrax, she has been successful in simplifying the contracting process and in developing effective communications with our clients. .
Prior to WCG Clintrax, Nicole served as a Contract Manager at PRA Health Sciences in the site-contracting department.
Nicole received her Bachelor of Sciences degree in Business Management from East Carolina University. While earning her degree at East Carolina University she was a student athlete participating in the East Carolina’s Track and Field program in the 100 meter and 400 meter hurdles.